Nautilus Biotechnology Reports Q1 GAAP EPS of -$0.12, Beats Estimates

Nautilus Biotechnology announced its GAAP EPS for the quarter was -$0.12, surpassing analyst estimates by $0.02. The company's earnings report provides an update on its financial performance.